Morales Mallory's Form 4 filing
Immuneering CorpIMRX · filed Mar 25, 2024
- Accession no.
- 0001790340-24-000038
- Filed
- Mar 25, 2024
- Trade date
- Mar 15-22, 2024
- Filing delay
- 10 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $4.01K. It was filed 10 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Morales MalloryCIK 0001941795 | Officer (Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Class A Common Stock | AGrant or awardAcquired | +4,344 | $1.62F3 | +$7,037.28 | 6,778 | Direct | |
| Mar 21, 2024 | Class A Common Stock | PPurchaseAcquired | +1,107 | $2.72F4 | +$3,011.04 | 7,885 | Direct | |
| Mar 22, 2024 | Class A Common Stock | PPurchaseAcquired | +393 | $2.55 | +$1,002.15 | 8,278 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on the Purchase Date of March 15, 2024.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.675 to $2.74. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
Referenced by the price of 1 transaction in Table I.